Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

MiMARK Diagnostics raises €4.2M seed round to commercialize non-invasive tests for endometrial cancer and endometriosis. Led by Clave Capital and others, they aim to advance their first product to market.

PRIVATEAug 26, 2026•about 3 hours ago

Amount Raised

€4.2 Million

Round Type

Seed

BarcelonaBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics

Investors

Canterbury ScientificInvereadyCdti InnvierteWa4 SteamNamarel VenturesNara CapitalClave Capital

Description

Barcelona-based MiMARK Diagnostics has raised €4.2 million in a seed round to develop non-invasive tests for women's health. The round is notable for its size within Spain's health sector. Their lead product aims to streamline testing procedures for endometrial cancer and endometriosis. MiMARK is now seeking an additional €8 million to further scale its operations.

Company Information

Company

MiMARK Diagnostics

Location

Barcelona, Catalonia, Spain

About

MiMARK Diagnostics is a Barcelona-based company focused on developing non-invasive diagnostic tests for women's health, particularly for endometrial cancer and endometriosis. It aims to replace painful biopsies with simpler and quicker testing methods. Founded in 2021, the company has spun out from the Vall d'Hebron Institute of Research and is advancing its product offerings to market. Their lead product, GyLDEC, targets post-menopausal women with abnormal uterine bleeding.

Don't miss MiMARK Diagnostics's next move

Get an email the moment MiMARK Diagnostics raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for MiMARK Diagnostics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

MiMARK Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.